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Summary We studied the incidence and survival rates for the histological subtypes of non-small-cell lung cancer, using data from the
Eindhoven Cancer Registry over the period 1975-94. The proportions with adenocarcinoma and large-cell undifferentiated carcinoma
increased from 11% to 21% and from 11% to 15%, respectively, while those with squamous cell carcinoma decreased from 78% to 62%. The
increase in the proportion with adenocarcinoma was only found among men. Although the overall prognosis for patients with non-small-cell
lung cancer has remained unchanged, there have been divergent changes between morphological subtypes. Relative 1- and 5-year survival
rates for squamous cell carcinoma have improved slightly from 48% to 51% and from 14% to 16%, respectively, because of an increase in the
proportion with localized tumours, while relative 1- and 5-year survival rates for adenocarcinoma have decreased from 59% to 45% and from
28% to 18%, respectively, because of a decrease in localized tumours. The proportion with localized tumours and the relative 1-year survival
for large-cell undifferentiated carcinoma (about 18% and 30% respectively) were markedly lower. The divergent trends could partly be
explained by changes in the histological classification of tumours, but changes in patterns of risk and biological behaviour of adenocarcinoma
cannot be excluded.
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Overall survival ofpatients with lung cancer is poor, but it is better
for non-small-cell than for small-cell tumours. Although non-
small-cell lung cancer is often considered to be one clinically
uniform category, several studies indicate that survival may differ
according to histological subtype, being better for squamous cell
carcinoma and adenocarcinoma than for large-cell undifferentiated
carcinoma (Capewell, 1987; Sant et al, 1992; Hilsenbeck et al,
1993; Travis et al, 1995). The morphological distribution of non-
small-cell lung cancers has been changing in many countries,
including the southeastern area of The Netherlands: the incidence
rates for adenocarcinoma and large-cell undifferentiated carci-
noma have increased, whereas those for squamous cell carcinoma
have decreased (Zheng et al, 1994; Janssen-Heijnen et al, 1995;
Travis et al, 1995; Levi et al, 1997; Russo et al, 1997). The overall
survival rates for non-small-cell lung cancer, however, have not
changed over time (Clerici et al, 1994). We studied the changes in
incidence and survival rates for unselected patients with non-
small-cell lung cancer in the southeastern area ofThe Netherlands
since 1975, separately for each histological subtype.
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PATIENTS AND METHODS
The patient data were obtained from the Eindhoven Cancer
Registry, which serves the Dutch province of North Brabant and
the northern part of the adjacent province of Limburg, an area
characterized by a high incidence of lung cancer and by good
access to specialized care (medically, financially and geographi-
cally). The data were derived directly from clinical records of
community hospitals and the Department of Radiotherapy,
Catharina Hospital, Eindhoven, The Netherlands upon notification
by three regional pathological laboratories and hospital record
offices. Despite the lack of access to death certificates, the infra-
structure of and good access to Dutch health care facilities and the
notification procedures used have made it possible to establish
cancer registries with a completeness exceeding 95% (Schouten et
al, 1993). The percentage of clinical diagnoses without histolog-
ical confirmation remained steady at 5% forpatients aged younger
than 70 years and 11% for those over 70 years. Between 1975 and
1994, 10 149 lung cancer patients were diagnosed: 7273 non-
small-cell lung cancer, 1796 small-cell lung cancer, 471 other lung
tumours and 609 clinically diagnosed lung tumours. There was a
combination of passive and active follow-up of all patients diag-
nosed up to 31 December 1992. The latest follow-up to determine
vital status by the municipal population administrations occurred
on 1 April 1994: 538 patients (8.5%) were still alive, 5738 patients
(91.1%) had died and 22 patients (0.4%) were lost to follow-up.
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Table 1 Characteristics of patients with non-small-cell lung cancer diagnosed between 1975 and 1994, according to period
1975-79 1980-84 1985-89 1990-94
No. % No. % No. % No. %
Sex
Male 1423 95 1695 94 1761 90 1737 87
Female 67 5 117 6 205 10 268 13
Age (years)
<70 979 66 1130 62 1188 60 1186 59
.70 511 34 682 38 778 40 819 41
Histology
Squamous cell 1163 78 1324 73 1300 66 1243 62
Adenocarcinoma 170 11 295 16 397 20 425 21
Large-cell undifferentiated 157 11 189 11 239 12 298 15
Other 0 0 4 0 30 2 39 2
Stage of disease
Age <70 years
Localized a 368 33 424 36 395 33
Non-localized a 694 61 694 58 726 61
Unknown a 68 6 70 6 65 6
Age .70 years
Localized a 170 25 252 33 292 36
Non-localized a 378 55 382 49 378 46
Unknown a 134 20 144 18 149 18
Therapy
Age <70 years
Surgery 321 33 317 28 338 28 327 28
Surgery and radiotherapy 58 6 98 9 115 10 112 9
Radiotherapy 372 38 480 42 533 45 507 43
Chemotherapy 56 5 36 3 16 1 11 1
Other or none 172 18 199 18 186 16 229 19
Age .70 years
Surgery 42 8 61 9 99 13 140 17
Surgery and radiotherapy 8 2 19 3 22 3 27 4
Radiotherapy 238 47 347 51 359 46 386 47
Chemotherapy 30 6 8 1 6 1 2 0
Other or none 193 37 247 36 292 37 264 32
Total 1490 1812 1966 2005
aOnly data on tumour stage collected since 1980 can be considered to be reliable.
Table 2 Trends in stage distribution of non-small-cell lung cancer, according to histological type (%)
Histology Stage 1980-84 1985-89 1990-94
(%)
Squamous cell Localized 30 37 39
Non-localized 58 51 49
Unknown 12 12 12
Total (n) 1324 1300 1243
Adenocarcinoma Localized 38 34 32
Non-localized 52 58 59
Unknown 10 8 9
Total (n) 295 397 425
Large-cell undifferentiated Localized 15 20 18
Non-localized 78 71 75
Unknown 7 9 7
Total (n) 189 239 298






























Figure 1 Trends in treatment of patients with non-small-cell lung cancer,
according to histological type. BE, Other or none; D1, chemotherapy; LI,
radiotherapy; 3 surgery and radiotherapy; C], surgery. A, squamous cell
carcinoma; B, adenocarcinoma; C, large-cell carcinoma
Non-small-cell lung tumours were classified as: squamous cell
carcinoma, adenocarcinoma, large-cell undifferentiated carci-
noma, and some rare subtypes (adenosquamous cell carcinoma,
adenoid cystic carcinoma, mucoepidermoid carcinoma and others)
according to the WHO classification (WHO, 1982). Stage of
disease was recorded on the basis of clinical and/or pathological
examination; if available, the post-operative TNM was used,
otherwise the clinical TNM. Two categories were considered:
localized (stages I and II) and non-localized [stages III (a and b)
and IV], according to the Tumour-Node-Metastasis (TNM)
system of the Union Internationale Contre le Cancer, version 4
(Mountain, 1986). Data on tumour stage collected since 1980 can
be considered to be reliable. For analysis of treatment policy, the
clinical TNM was used. Treatment (only recorded when given
within the first 6 months after diagnosis) was divided into five
categories: surgery, surgery and radiotherapy, radiotherapy,
chemotherapy and 'other or none', including palliative therapy
other than surgery, chemotherapy or radiotherapy.
Relative survival for patients diagnosed up to 1992 was calcu-
lated as the ratio of observed to expected actuarial rates. Expected
survival rates were calculated from life tables for regional male
and female populations (supplied by Statistics Netherlands),
compiled according to 5-year age groups and year of diagnosis.
The risk of death due to lung cancer was estimated using a
computer program from the Finnish Cancer Registry (Hakulinen
and Abeywickrama, 1985). The standard errors of survival rates
were calculated according to Greenwood's formula (Greenwood,
1926). Survival rates were computed according to sex, age group
(<70 years, >70 years), histological subtype and stage of disease
forthe periods 1975-79, 1980-84, 1985-89 and 1990-92. Patients
who were diagnosed at autopsy or died within the first month of
diagnosis were excluded from the survival analysis (n = 475, 8%).
RESULTS
General characteristics
In total, 7273 patients with non-small-cell lung cancer were diag-
nosed between 1975 and 1994 (6616 men and 657 women). The
age-standardized incidence rate (WSR) for men increased from 59
per 100 000 person-years in 1975 to 67 in 1983 and then
decreased to 52 in 1995. Thepeak incidence rate for squamous cell
carcinoma was reached in 1978, while for adenocarcinoma it was
1985. The incidence rate for women increased from 3 per 100 000
in 1975 to 9 in 1995. The incidence increased for every histolog-
ical type. The male - female ratio decreased from 21 in 1975-79 to
6 in 1990-94 and the proportion ofelderly patients increased from
34% to 41%. The characteristics ofthe patients are shown in Table
1. Squamous cell carcinoma was the most frequent histological
type, but the proportions with adenocarcinoma (only among men)
or large-cell undifferentiated carcinoma have increased markedly.
Most patients (50%) received radiotherapy and almost 30% of all
patients underwent surgical resection (almost 40% of younger and
15% of older patients), of whom 6% had combined surgery and
radiotherapy. The use of chemotherapy (in the 1970s mainly
endoxan) has decreased markedly.
Trends in stage distribution and treatment policy
The proportion of those with squamous cell carcinoma who were
aged 70 years or more increased from 37% in 1975-79 to 46% in
1990-94, forthose with adenocarcinoma from 24% to 28% and for
those with large-cell undifferentiated carcinoma from 27% to 38%.
For patients with squamous cell carcinoma, the proportion with
localized tumours has increased since 1980. However, for those
with adenocarcinoma, the opposite trend was found. For patients
with large-cell undifferentiated carcinoma, the proportion with
localized tumours has not changed and was clearly lower than that
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for patients with squamous cell carcinoma or adenocarcinoma
(Table 2). Between 1980 and 1994,just over 85% of all adenocar-
cinoma patients with a localized tumour underwent surgical resec-
tion, in contrast to 55-65% of patients with squamous cell or
large-cell undifferentiated carcinoma. For patients with a non-
localized tumour, the percentages undergoing surgical resection
were similar for all three histological types (5-10Y%). Most patients
with a non-localized tumour received radiotherapy (Figure 1).
Survival
Overall, relative 1-, 5- and 10-year survival rates for patients with
non-small-cell lung cancer (48%, 16% and 10% respectively) did
not change between 1975 and 1992 and were similar for men and
women. Relative 1- and 5-year survival rates were highest for
patients younger than 70 years ofage and for those with a localized
tumour. In addition to being dependent on age and stage, survival
clearly varied according to histological subtype. The relative 1-year
survival rate for patients with squamous cell carcinoma has
increased slightly from 48% in 1975-79 to 51% in 1990-92, while
that for patients with adenocarcinoma decreased markedly from
59% to 45%; the same trends were found for the 5-year survival
rates. Relative survival rates for patients with large-cell undifferen-
tiated carcinoma were much lower and have not changed signifi-
cantly over time (Table 3). The decrease in survival found for
adenocarcinoma was greatest for patients younger than 70 years of
age (1-year survival rates decreasing from 63% to 46%) and for
men (1-year survival rates decreasing from 61% to 45%). After
stratification according to stage, relative 1- and 3-year survival
rates for all three histological subtypes did not change over time.
DISCUSSION
In the southeastern area of The Netherlands, the prognosis for
patients with non-small-cell lung cancer has remained constant
between 1975 and 1992, despite an increase in the number ofchest
physicians from 10 to 20 per one million inhabitants. Among
patients with non-small-cell lung cancer, the proportions with
adenocarcinoma and large-cell undifferentiated carcinoma have
increased, while those with squamous cell carcinoma have
decreased. The percentage of localized tumours among patients
with adenocarcinoma has decreased in contrast to squamous cell
carcinoma. The survival rate for patients with squamous cell carci-
noma has increased slightly since 1975, while that for adenocarci-
noma has decreased markedly, especially among patients younger
than 70 years of age and men. However, the changes in survival
disappeared after stratification according to stage of disease.
While the incidence of large-cell undifferentiated carcinoma
increased, neither stage distribution nor prognosis for these
patients has changed over time, both being much worse than those
found for squamous cell carcinoma and adenocarcinoma.
The incidence rates for squamous cell lung cancer have been
decreasing in Western countries (Dodds et al, 1986; Wu et al, 1986;
Zheng et al, 1994; Janssen-Heijnen et al, 1995) 15-25 years after
the decrease in the percentage of smokers. Absolute and propor-
tional increases in the incidence of pulmonary adenocarcinoma
have been noticed in many countries (Dodds et al, 1986; Wu et al,
1986; Zheng et al, 1994; Janssen-Heijnen et al, 1995; Travis et al,
1996; Levi et al, 1997; Russo et al, 1997). The extent to which
changes in diagnostic techniques and/or classification criteria were
responsible for the increase in adenocarcinoma is likely to be
limited; despite increased application of better diagnostic tech-
niques applied by more chest physicians, the percentage of local-
ized tumours has decreased. The few solid carcinomas with mucus
production, only classified as adenocarcinoma after 1981 (WHO,
1982), cannot be responsible for the increase. Furthermore, in our
data set, the rise in adenocarcinoma was not caused by an increase
in bronchioloalveolar carcinoma, as has been observed by others
(Barsky et al, 1994; Barkley and Green, 1996). Changes in expo-
sure to risk factors, such as the increased use of filter cigarettes
(Morabia and Wynder, 1991; Thun et al, 1997), probably play a
role. Large-cell undifferentiated carcinoma has frequently been
called a 'waste-basket' or nonentity, because the carcinomas are so
poorly differentiated that squamous or glandular differentiation is
no longerevident at the light microscopic level. Thus, the incidence
varies with the criteria used to classify the other forms of non-
small-cell lung cancer. Together, strict criteria for the diagnosis of
squamous cell carcinoma and adenocarcinoma and small biopsies
that diminish the chance of detecting focal signs of differentiation
may have led to more large-cell undifferentiated carcinomas
Table 3 Relative 1- and 5-year survival rates for patients with non-small-cell lung cancer, according to period
Relative 1-year survival Relative 5-year survival
1975-79 1980-84 1985-89 1990-92 1975-79 1980-84 1985-89
% (s.e.) % (s.e.) % (s.e.) % (s.e.) % (s.e.) % (s.e.) % (s.e.)
All NSCLC 48(1) 47(1) 48(1) 47(2) 15(1) 15(1) 17(1)
Squamous cell 48 (2) 49 (1) 51 (2) 51 (2) 14 (1) 14 (1) 16 (1)
Adenocarcinoma 59 (4) 49 (3) 46 (3) 45 (4) 28 (4) 24 (3) 18 (2)
Large-cell undifferentiated 32 (4) 31 (4) 30 (3) 26 (4) 11 (3) 7 (2) 10 (2)
Men 47 (1) 47 (1) 48 (1) 47 (2) 15 (1) 15 (1) 16 (1)
Women 54 (7) 45 (5) 46 (4) 44 (5) 21 (6) 18 (4) 17 (3)
Age <70 years 50 (2) 50 (2) 52 (2) 48 (2) 18 (1) 19 (1) 19 (1)
Age 70+ years 42 (2) 41 (2) 41 (2) 46 (3) 8 (2) 6 (1) 11 (1)
Localized a 76 (2) 78 (2) 75 (2) a 37 (2) 38 (2)
Non-localized a 32 (2) 30 (2) 29 (2) a 4 (1) 4 (1)
aOnly data on tumour stage collected since 1980 can be considered to be reliable.
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(Gazdar and Linnoila, 1988); sometimes the term is used to distin-
guish them from small-cell tumours. In the mid-1990s, 18 of 52
large-cell undifferentiated carcinomas (35%) could be reclassified
as squamous cell carcinoma and seven (13%) as adenocarcinoma.
Thus, the observed decrease in squamous cell carcinoma may also
be because ofthe increase in large-cell undifferentiated carcinoma,
whereas the observed increase in adenocarcinoma may be even
greater.
In 1975-79, relative 1-year survival was highest for patients
with adenocarcinoma, but in 1980-84 the relative survival for
patients with squamous cell carcinoma surpassed that for adeno-
carcinoma. A shift in classification of the more aggressive squa-
mous cell tumours towards large-cell undifferentiated tumours or
earlier diagnosis because of the use of more refined techniques
may have occurred.
Despite increased application of better diagnostic techniques
applied by more chest physicians, the percentage of patients with
localized adenocarcinoma has decreased, with a corresponding
decrease in survival. The question is whether adenocarcinoma, espe-
cially among younger patients, has become a more aggressive
tumour. Despite a higher resection rate and more younger patients,
the survival rate for patients with localized adenocarcinoma was not
much higher than that for patients with localized squamous cell
carcinoma, as was also found in the USA (Humphrey etal, 1990) but
not in Scotland (Capewell, 1987). In a study in Germany, micro-
metastases inpatients with apparently localized lung canceroccurred
more often in adenocarcinoma patients (Pantel et al, 1996).
Between 1978 and 1985, 1-year survival rates in Europe varied
between 21% and 42%, and 5-year rates between 6% and 15%.
The rates were highest in the southeastern area ofThe Netherlands,
Finland, Switzerland and France and lowest in England, Denmark
and Scotland (Berrino et al, 1995). As the Eindhoven Cancer
Registry is a registry without death certificate-only (DCO) cases,
some elderly patients and patients with poor chances of survival
may have been missed. However, the proportion of missing lung
cancer patients in a similar Dutch cancer registry was estimated to
be less than 5% (Schouten et al, 1993). Survival of lung cancer,
regardless of histological type, in European countries has not
improved over time (Berrino et al, 1995). In Yorkshire, England,
UK, a modest improvement in 2-year survival between 1976 and
1983 was found for patients with non-small-cell lung cancer, espe-
cially for patients over 70 years and those with squamous cell
carcinoma (Connolly et al', 1990); however, the percentage with an
unknown histology in Yorkshire was high (Crawford and
Atherton, 1994).
In conclusion, the prognosis for patients with non-small-cell
lung cancer did not change significantly between 1975 and 1994.
However, there were changes between morphological subtypes:
the prognosis for squamous cell carcinoma improved slightly,
probably because of an increase in the proportion with localized
tumours, while the stage of disease at diagnosis and the prognosis
for adenocarcinoma patients became worse, especially for younger
patients. For patients with large-cell undifferentiated carcinoma,
neither stage distribution nor prognosis changed during that
period. The divergent trends may be partly explained by changes
in histological tumour typing, but changes in patterns of risk and
biological behaviour of adenocarcinoma cannot be excluded.
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